We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+2.65%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$1.9B
AUM Growth
+$2.05M
Cap. Flow
-$4.81M
Cap. Flow %
-0.25%
Top 10 Hldgs %
9.55%
Holding
811
New
280
Increased
125
Reduced
151
Closed
255

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$19.4M
2
MU icon
Micron Technology
MU
+$19.3M
3
RHT
Red Hat Inc
RHT
+$18.7M
4
LVS icon
Las Vegas Sands
LVS
+$18.5M
5
ORCL icon
Oracle
ORCL
+$18.2M

Top Sells

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$19.5M
2
CTSH icon
Cognizant
CTSH
+$19.4M
3
USB icon
US Bancorp
USB
+$19.1M
4
GS icon
Goldman Sachs
GS
+$19M
5
JPM icon
JPMorgan Chase
JPM
+$18.9M

Sector Composition

Rank Sector Weight
1 Technology 19.25%
2 Healthcare 16.41%
3 Consumer Discretionary 13.18%
4 Industrials 12.87%
5 Financials 11.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
1
Micron Technology
MU
$930B
$19.6M 1.03%
+507,240
New +$19.3M
ORCL icon
2
Oracle
ORCL
$349B
$19.2M 1.01%
+336,781
New +$18.2M
RHT
3
DELISTED
Red Hat Inc
RHT
$19M 1%
+101,290
New +$18.7M
RTX icon
4
RTX Corp
RTX
$293B
$19M 1%
+232,083
New +$19.4M
LVS icon
5
Las Vegas Sands
LVS
$32.1B
$17.9M 0.94%
302,933
+299,400
+8,474% +$18.5M
MS icon
6
Morgan Stanley
MS
$333B
$17.7M 0.94%
404,901
-37,100
-8% -$1.65M
NSC icon
7
Norfolk Southern
NSC
$77.2B
$17.4M 0.92%
+87,113
New +$17.3M
HUM icon
8
Humana
HUM
$46B
$17.1M 0.9%
64,377
+57,200
+797% +$14.5M
BIIB icon
9
Biogen
BIIB
$29.8B
$17.1M 0.9%
+73,000
New +$16.9M
AGN
10
DELISTED
Allergan plc
AGN
$17M 0.9%
101,800
+33,300
+49% +$4.61M
UNP icon
11
Union Pacific
UNP
$177B
$17M 0.9%
100,689
-14,689
-13% -$2.52M
MRK icon
12
Merck
MRK
$325B
$16.7M 0.88%
208,638
+190,946
+1,079% +$14.6M
DG icon
13
Dollar General
DG
$27.8B
$16.6M 0.88%
123,038
-36,700
-23% -$4.64M
COP icon
14
ConocoPhillips
COP
$138B
$16.3M 0.86%
267,802
-17,300
-6% -$1.08M
DD icon
15
DuPont de Nemours
DD
$19.1B
$15.8M 0.84%
168,100
+22,173
+15% +$2.65M
SCHW
16
Charles Schwab
SCHW
$184B
$15.7M 0.83%
391,734
+226,356
+137% +$9.87M
PGR icon
17
Progressive
PGR
$129B
$15.1M 0.8%
+188,653
New +$14.6M
ABBV icon
18
AbbVie
ABBV
$467B
$15M 0.79%
205,958
+189,200
+1,129% +$14.9M
LYB icon
19
LyondellBasell Industries
LYB
$19B
$14.8M 0.78%
171,736
+165,300
+2,568% +$14.1M
BAC icon
20
Bank of America
BAC
$438B
$14.8M 0.78%
509,915
-184,900
-27% -$5.33M
BNY
21
Bank of New York Mellon
BNY
$106B
$14.3M 0.76%
+324,697
New +$15.3M
CELG
22
DELISTED
Celgene Corp
CELG
$13.7M 0.72%
147,919
+3,800
+3% +$361K
VEEV icon
23
Veeva Systems
VEEV
$32.8B
$13.7M 0.72%
+84,221
New +$12.3M
HON icon
24
Honeywell
HON
$78.7B
$13.6M 0.72%
+82,884
New +$13.2M
AMGN icon
25
Amgen
AMGN
$211B
$13.5M 0.71%
73,213
+20,613
+39% +$3.69M

Similar funds

Seven Eight Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Seven Eight Capital held 811 positions worth $1.9B, up 0.11% from $1.89B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Seven Eight Capital's Q2 2019 filing shows 280 new, 125 increased, 151 reduced and 255 closed positions. Its largest new stake was RTX Corp: 232,083 shares worth $19M. The largest sale was Monster Beverage, an estimated $19.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Seven Eight Capital's largest Q2 2019 buy was RTX Corp: 232,083 shares worth $19M.
  • Seven Eight Capital added most to Las Vegas Sands in Q2 2019, an estimated $18.5M increase.
  • Seven Eight Capital's biggest Q2 2019 reduction was Monster Beverage, cutting an estimated $19.5M.
  • Seven Eight Capital fully exited Cognizant in Q2 2019, selling an estimated $19.4M.
  • Seven Eight Capital's ten largest holdings make up 9.6% of its $1.9B portfolio in Q2 2019.
  • Seven Eight Capital opened 280 new positions and closed 255 in Q2 2019.
  • Seven Eight Capital's portfolio value rose 0.11% quarter-over-quarter to $1.9B.

Based on Seven Eight Capital's 13F filing for Q2 2019, filed 12 Aug 2019.